Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
Date:8/8/2013

SAN FRANCISCO, Aug. 8, 2013 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2013.

Cash and investments in marketable securities at June 30, 2013 were $226.9 million.

"I am very pleased with Nektar's performance this year," said Howard W. Robin, President and Chief Executive Officer of Nektar. "AstraZeneca has confirmed that they will be filing both the naloxegol NDA and MAA in September.  Naloxegol could be the first once-daily oral medication to treat patients with opioid-induced constipation.  In June, we announced positive data from our Human Abuse Liability study for NKTR-181, our wholly-owned analgesic molecule which has received Fast Track Status from the FDA.  The results clearly demonstrated that drug abusers could not discriminate NKTR-181 from placebo at doses that we know produced analgesia in earlier studies.  We are on track to report high-level results from the Phase 2 efficacy study of NKTR-181 in chronic pain patients this summer.  Finally, we recently completed enrollment in our Phase 3 study of NKTR-102 ahead of schedule.  NKTR-102 is the first long-acting topoisomerase I inhibitor being developed for the treatment of advanced breast cancer and we expect survival data from this pivotal trial next year."

Revenue in the second quarter of 2013 was $33.9 million as compared to $23.7 million in the second quarter of 2012. Year-to-date revenue for 2013 was $56.9 million as compared to $41.6 million in the first half of 2012.  Revenues included non-cash royalty revenue, related to our February 2012 royalty monetization, of $3.8 million and $8.2 million in the second quarter and first half of 2013, respectively, and $3.5 million in both the second quarter and first half of 2012. This non-cash royalty revenue is offset by non-cash inter
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
8. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
9. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
10. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
11. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Eli Lilly and Company (NYSE: LLY ) ... of its intent to end its contract with the ... Asymptomatic Alzheimer,s disease (A4) study. The A4 study is ... stage of Alzheimer,s disease in older individuals who have ... scan, but do not show symptoms of memory impairment. ...
(Date:8/4/2015)... 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... Ch.B., Sangamo,s executive vice president, research and development, will ... Therapeutic ® development programs and an overview of ... August 11, 2015, at the 2015 Wedbush Pacgrow Healthcare ... New York, NY . The presentation ...
(Date:8/4/2015)... Calif., Aug. 4, 2015  Xencor, Inc. (NASDAQ: ... engineered monoclonal antibodies for the treatment of autoimmune ... reported financial results for the second quarter ended June ... business highlights. "Currently eight XmAb® antibody ... and two internal. The accelerating momentum of this ...
Breaking Medicine Technology:Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Xencor Reports Second Quarter 2015 Financial and Operating Results 2Xencor Reports Second Quarter 2015 Financial and Operating Results 3Xencor Reports Second Quarter 2015 Financial and Operating Results 4Xencor Reports Second Quarter 2015 Financial and Operating Results 5Xencor Reports Second Quarter 2015 Financial and Operating Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 7Xencor Reports Second Quarter 2015 Financial and Operating Results 8Xencor Reports Second Quarter 2015 Financial and Operating Results 9
... ago, Keli Babcock faced a crisis. A medical condition was ... a ventilator. She couldn,t walk or even maneuver a manual ... But Keli wasn,t about to give in; she aspired to ... with a power wheelchair, one that is powered by batteries ...
... Innovative wireless technology is reshaping the healthcare landscape in ... of Wireless" webcast ( www.ctia.org ) focuses on new ... more value and better health. This is particularly true ... of the U.S. population suffers from at least one ...
Cached Medicine Technology:Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 2Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 3Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 4CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 2CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 3
(Date:8/5/2015)... ... , ... Stelari introduces their new collection, The Earth’s Song, inspired by the ... Earth’s Song. Combining fashion and activewear, Stelari’s new collection let’s you take your bohemian ... this collection is sure to make the spirit seeker swoon with prints as meaningful ...
(Date:8/5/2015)... ... August 05, 2015 , ... As the nation’s premier nonprofit ... and support in order to reduce the incidence of brain aneurysms and improve ... it has awarded the most funding in the 20-year history of the organization. ...
(Date:8/4/2015)... ... , ... MONTICELLO, Fla. – After completing 2,400 hours in the Clinical Pastoral ... as a clinician allowed Dr. Barbara Thomas-Reddick to gain the skills and ... patients, families, friends and staff, and she was able to witness after leaving the ...
(Date:8/4/2015)... Alexandria, VA (PRWEB) , ... August 04, 2015 , ... ... America applauds the introduction of the Mental Health Reform Act of 2015 ... toward making comprehensive mental health reform a reality in America. , “This legislation ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... uses Cloud innovation to consolidate oncology patient assistance programs. Through a secure web ... of access. assistPoint is an enterprise level, cloud-based application and workflow solution. This ...
Breaking Medicine News(10 mins):Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:assistPoint.com Web Site Launched 2
... centers, universities and public health institutions from Miami to ... community disaster readiness and recovery through research programs targeting ... The consortium, known as SECURE (Science, Education, Community United ... $4 million grant from the National Center on Minority ...
... today the publication of the May 2010 issue of ... polemic issues related to cosmetic surgery, body image and ... information about the risks of complications and failure rate ... controversy generated by the use of available resources, including ...
... applied to HIV care, the community-based model of ... virologic outcomes, but significantly improves patient survival. This ... Bloomberg School of Public Health, in collaboration with ... who conducted the first randomized controlled trial of ...
... New York University,s Center for Neural Science, has been ... Award for his work on how the brain reconstructs ... the award with William T. Newsome, a Stanford University ... a $1.3 million prize, the largest monetary prize in ...
... Researchers have discovered a new strain of bacteria that ... degrade polycyclic aromatic hydrocarbons, or PAHs environmental pollutants ... oil spills. Because of its unique characteristics, this ... the long-term cleanup of the massive Gulf Coast oil ...
... Diseases (DZNE), the UK Medical Research Council and ... a cooperation agreement that aims to establish and ... neurodegenerative diseases. At the signing of the agreement, ... governments emphasized the importance of international cooperation in ...
Cached Medicine News:Health News:Research alliance aims to help vulnerable communities cope with disaster 2Health News:Research alliance aims to help vulnerable communities cope with disaster 3Health News:Research alliance aims to help vulnerable communities cope with disaster 4Health News:Reproductive health matters addresses issues related to cosmetic surgery, body image and sexuality 2Health News:Directly observed HIV treatment by patient-nominated treatment supporter improves survival 2Health News:NYU's Movshon receives Champalimaud Vision Award for work on how brain reconstructs images 2Health News:New strain of bacteria discovered that could aid in oil spill, other environmental cleanup 2Health News:New strain of bacteria discovered that could aid in oil spill, other environmental cleanup 3Health News:DZNE, MRC and CIHR cooperation: Milestone for research on neurodegenerative diseases 2Health News:DZNE, MRC and CIHR cooperation: Milestone for research on neurodegenerative diseases 3
... The Tomey Pachymeter SP-3000 covers all ... the general ophthalmic health care., ,Compact design, ... the SP-3000 to be an "easy-to-use unit.,The ... 1500 mm gives you the possibility to ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
... combines three advanced technologies - plus ... refractive diagnostic workstation. Now, with a ... corneal topography, optical path difference (OPD) ... allows you to evaluate your patient ...
World's first commercially available vacuum assisted biopsy device for MRI....
Medicine Products: